ALDX
Aldeyra Therapeutics
$1.59
+$0.07 (+4.28%)Jul 27, 2026
Key metrics
The numbers that frame ALDX today
- Market cap
- $95.61M
- P/E (TTM)
- -3.5
- EV / FCF
- -1.8
- ROIC
- -576.7%
- Div yield
- 0%
- Debt / equity
- 0.4
- 52wk Low
- $1.07
- 52wk High
- $6.18
Growth
Revenue and earnings trend for ALDX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ALDX
Is Aldeyra Therapeutics a good buy?
No. Aldeyra Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Aldeyra Therapeutics is selling at a very high price.
What is the market capitalization of ALDX?
Aldeyra Therapeutics's market capitalization is $95.61M.
What is the P/E ratio for ALDX stock?
Aldeyra Therapeutics's current P/E ratio is -3.5.
What is the 52-week high for ALDX stock?
The 52-week high for Aldeyra Therapeutics is $6.18. The current close of $1.59 is 74.3% below that high.
What is the 52-week low for ALDX stock?
The 52-week low for Aldeyra Therapeutics is $1.07. The current close of $1.59 is 48.1% above that low.
Does ALDX stock pay dividends?
Aldeyra Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ALDX?
Aldeyra Therapeutics's Debt / Equity ratio is 0.37.